Neuromama saga is a cautionary tale for wannabe penny stock investors
August 17, 2016 at 14:01 PM EDT
SEC has questioned claims by Neuromama since 2014 but didn’t suspend its stock until Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.